logo

For the Inventor, By the Inventor

Upper Montclair, NJ, United States of America

Milan R Uskokovic

USPTO Granted Patents = 118 

 

Average Co-Inventor Count = 2.8

ph-index = 15

Forward Citations = 1,041(Granted Patents)

Forward Citations (Not Self Cited) = 906(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Montclair, NJ (US) (1976)
  • Upper Montclair, NY (US) (1990)
  • Upper Montclair, N (1994)
  • Upper Montclair, NJ (US) (1976 - 2009)

Company Filing History:

goldMedal113 out of 4,948 
 
Hoffmann-la Roche Inc.
 patents
silverMedal6 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
bronzeMedal1 out of 28 
 
The United States of America As Represented by the Department of
 patents
4. 1 out of 5,469 
 
The University of Texas System
 patents
5. 1 out of 322 
 
Roche Palo Alto LLC
 patents
6. 2 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-2009

Loading Chart...
Loading Chart...
Areas of Expertise:
Vitamin D3 Analogues
Fluorinated Compounds
Antipsoriatic Agents
Hyperproliferative Skin Diseases
Osteoporosis Treatment
Synthesis Of Metabolites
Cholecalciferol Derivatives
Deuterated Analogs
Photodamage Reversal
Steroid Intermediates
3-Desoxy Vitamin D3
Methods Of Treatment
118 patents (USPTO):Explore Patents
1. 7491711 - Methods of treatment using 3-desoxy vitamin D3 analogs (2009-02-17),
2. 6559138 - 3-Desoxy-vitamin D3 analog esters (2003-05-06),
3. 6492353 - 1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs (2002-12-10),
4. 6452028 - Vitamin D3 analogs (2002-09-17),
5. 6331642 - Vitamin D3 analogs (2001-12-18),
6. 6329538 - Vitamin D3 analogs (2001-12-11),
7. 6040461 - Synthesis of 3-epi vitamin D.sub.3 metabolites and analogs (2000-03-21),
8. 6030963 - 16-ene-26,27-bishomo cholecalciferols (2000-02-29),
9. 6030962 - Vitamin D.sub.3 analogs with bis C-20 side chains (2000-02-29),
10. 6008209 - Method of using vitamin D.sub.3 analogs with bis C-20 side chains (1999-12-28),
11. 5939408 - Vitamin D.sub.3 analogs (1999-08-17),
12. 5891866 - Methods of treatment (1999-04-06),
13. 5888994 - Fluorinated Vitamin D.sub.3 analogs (1999-03-30),
14. 5872113 - Fluorinated vitamin D3 analogs (1999-02-16),
15. 5856317 - Methods of treatment (1999-01-05),

Title: Unveiling the Innovations of Inventor Milan R Uskokovic

Introduction:

Milan R Uskokovic, a prolific inventor hailing from Upper Montclair, NJ, has made significant contributions to the field of healthcare with a staggering 118 patents to his name. His groundbreaking work has revolutionized treatments for various medical conditions, leaving a lasting impact on the industry.

Latest Patents:

Among his latest patents is the development of methods of treatment using 3-desoxy vitamin D3 analogs. This innovation presents a novel approach to addressing osteoporosis, hyperparathyroidism, and autoimmune diseases by administering specific analogs to patients. Additionally, Uskokovic's work on 3-Desoxy-vitamin D3 analog esters showcases his commitment to advancing medical therapies.

Career Highlights:

Milan R Uskokovic has honed his craft at notable companies such as Hoffmann-La Roche Inc., where his inventive spirit thrived. This esteemed pharmaceutical company served as a fertile ground for Uskokovic to nurture his ideas and bring them to life through cutting-edge research and development.

Collaborations:

Throughout his illustrious career, Milan R Uskokovic has collaborated with esteemed colleagues such as Enrico G Baggiolini and Giacomo Pizzolato. Together, they have fostered a collaborative environment that has fueled innovation, leading to the successful realization of groundbreaking medical technologies.

Conclusion:

Inventor Milan R Uskokovic's remarkable journey stands as a testament to his unwavering dedication to pioneering advancements in healthcare. With a rich tapestry of patents and a legacy of transformative inventions, Uskokovic continues to shape the landscape of medical treatments, leaving an indelible mark on the industry for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…